Livongo Health
2020
$18.5B
Teladoc Health
Acquisitions
4
Major Deals Covered
$19.6B
Disclosed Deal Value
Teladoc Health's largest disclosed acquisition here is InTouch Health for $600 in 2020. This page covers 4 major deals from 2015 to 2020, each with its price where disclosed and the reason behind it.
| Company | Year | Price | Purpose |
|---|---|---|---|
| 2020 | Undisclosed | Transformative digital chronic disease management platform for diabetes, hypertension, and weight health. | |
| 2020 | Undisclosed | Inpatient hospital telemedicine systems, tele-stroke, and tele-ICU clinical hardware and software. | |
| 2017 | Undisclosed | Global medical expert opinion network providing complex clinical reviews and second opinions. | |
| 2015 | Undisclosed | Direct-to-consumer virtual behavioral counseling and mental health therapy platform. |
2020
$18.5B
2020
$600M
2017
$440M
2015
$17M
Under CEO Charles Divita Jr., Teladoc Health is executing four core turnaround and growth initiatives: (1) Expanding Primary360 Enterprise Adoption: Scaling virtual primary care agreements with national health plans to serve as the default primary care provider for distributed workforces; (2) Integrating Weight Management & GLP-1 Support: Expanding the Livongo chronic care platform to offer comprehensive clinical obesity management, nutrition guidance, and GLP-1 companion therapy programs; (3) Deploying Ambient AI Clinical Scribes: Integrating ambient clinical voice AI (via Microsoft Nuance DAX) to auto-generate clinical consultation notes, reducing physician charting burden and expanding clinical capacity; and (4) International Enterprise Healthcare Expansion: Growing B2B telehealth operations across Canada, the UK, Europe, Australia, and Latin America.
Teladoc Health operates a diversified recurring virtual care business model spanning B2B enterprise subscriptions, per-visit fees, and direct-to-consumer digital health subscriptions: (1) Integrated Care PMPM Subscriptions (~56% of revenue / ~$1.45B), charging employers and health plans a predictable Per-Member-Per-Month (PMPM) access fee covering 92M+ members, supplemented by visit co-pays; (2) Chronic Condition Enrollment Fees: Monetizing bundled per-participant monthly fees for Livongo diabetes, hypertension, and weight management programs that supply smart cellular blood glucose meters, test strips, and digital coaching; (3) BetterHelp Direct-to-Consumer Subscriptions (~44% of revenue / ~$1.15B), charging consumers monthly recurring subscriptions ($260–$360/month) for weekly live video therapy sessions and unlimited text messaging with licensed therapists; and (4) Enterprise Hospital Virtual Care Systems: Selling specialized hardware carts, software licenses, and tele-stroke/tele-ICU networks to acute hospital systems. Teladoc generates gross margins near 70% and over $350 million in annual adjusted EBITDA.
Teladoc Health pursues a disciplined, strategic M&A approach focused on acquiring proprietary technologies, expanding customer distribution reach, and unlocking operational cost synergies rather than pursuing unselective scale.
Transformative transactions in Teladoc Health's history include pivotal mergers and acquisitions that secured key regional footprints, consolidated core market share, and brought proprietary software intellectual property in-house.
Teladoc Health deploys dedicated integration teams to harmonize core software stacks, align regulatory compliance systems, and unite company cultures while preserving entrepreneurial agility.
Yes, Teladoc Health periodically evaluates its corporate portfolio, strategically divesting non-core or non-strategic assets to redeploy capital into high-margin core operational divisions.
Compare corporate acquisition records, deal values, and strategic targets
Explore Teladoc Health
Core profile pages, founders and related research hubs for this company.